Mark Richards,Chee Wee Phoon,Mun Kin Lee,RICHARDS, Mark,PHOON, Chee Wee,LEE, Mun Kin
申请号：
US13377130
公开号：
US20120083532A1
申请日:
2010.06.11
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to the use of a compound represented by the general formula (I), and pharmaceutically acceptable salts thereof, wherein: n is an integer from 2 to 5 p is an integer from 0 to 4 R1 is selected from the group consisting of a hydroxyl group, an alkoxy group, a thiol group, a thioether group, and an amino group, wherein at least two of R1 is a hydroxyl group, a thiol group or an amino group, with the proviso that wherein n is 2, R1 is not on the carbon-2 position and the carbon-5 position of the phenyl group R2 and R3 are independently a methylene group or a nucleophile, with the proviso that at least one of R2 and R3 is a nucleophile group Z is an oxygen (O) atom or sulfur (S) atom T is hydrogen or an optionally substituted aliphatic group in the manufacture of a medicament for treating a patient in need of cell therapy.
